Product Description
The Capnostream 20p patient monitor with Microstream technology provides a complete measurement of a patients oxygenation and ventilation status.
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Device
Route of Administration: Nasal
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Medtronic
Company Location: DUBLIN L2 2
Company CEO: Geoffrey S. Martha
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
NCT05368740 | N/A |
Completed |
Neuromyelitis Optica|Obesity, Morbid|Anesthesia Related|Hypertension, Renal|Pulmonary Heart Disease|Heart Block|Kidney Diseases|Pain, Postoperative |
2021-01-31 |
|
MDT17026 | N/A |
Terminated |
Other |
2019-12-14 |
|
2018P000152 | N/A |
Completed |
Other |
2019-03-08 |
|
D0006746A | N/A |
Completed |
Pulmonary Valve Insufficiency|Respiratory Insufficiency |
2014-09-01 |